What is the difference between the urine albumin-to-creatinine ratio and the urine total protein-to-creatinine ratio?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Albumin/Creatinine Ratio vs Total Protein Urine: Key Differences

The urine albumin-to-creatinine ratio (ACR) specifically measures albumin excretion and is the preferred test for detecting early kidney damage (microalbuminuria), while the urine protein-to-creatinine ratio (PCR) measures all urinary proteins and is more appropriate for monitoring established proteinuria in non-diabetic chronic kidney disease. 1

What Each Test Measures

ACR measures only albumin, the smallest and most abundant protein that leaks through damaged glomeruli in early kidney disease. This makes it the most sensitive marker for detecting early kidney injury, particularly in diabetic nephropathy.

PCR measures total protein, which includes albumin plus all other urinary proteins (non-albumin proteins or NAP). These additional proteins—such as tubular proteins, immunoglobulins, and other larger molecules—reflect different types of kidney injury, particularly tubular damage 2.

Clinical Testing Hierarchy

According to KDIGO 2024 guidelines, the testing preference order is 1:

For initial albuminuria testing (adults):

  • First choice: Urine ACR on first morning void
  • Second choice: Reagent strip for albumin with ACR confirmation

If measuring total protein:

  • First choice: Urine PCR
  • Second choice: Reagent strip for total protein with automated reading
  • Third choice: Reagent strip with manual reading

For children specifically, both PCR and ACR should be obtained simultaneously on first morning samples 1.

The Albumin-to-Protein Relationship

The proportion of albumin within total protein varies significantly based on disease severity and type. In normal to mild proteinuria, albumin comprises less than 30% of total protein, but this increases to approximately 70% in severe proteinuria 3. This non-linear relationship means you cannot simply convert between the two measurements using a fixed multiplier.

Non-albumin proteinuria (calculated as PCR minus ACR) independently predicts mortality risk even after adjusting for albuminuria levels 2, 4. In fact, patients with severe proteinuria but normal albuminuria have the highest mortality risk (adjusted HR 5.25), suggesting that non-albumin proteins carry important prognostic information 4.

When to Use Each Test

Use ACR when:

  • Screening for early diabetic kidney disease
  • Detecting microalbuminuria (30-300 mg/g)
  • Following current guidelines for diabetes management
  • Initial kidney disease screening in any patient

Use PCR when:

  • Monitoring established non-diabetic CKD
  • Proteinuria is already in the nephrotic range
  • Historical data exists only as PCR (most renoprotective trials used PCR) 5
  • Cost is a significant concern

Measure both simultaneously when:

  • Evaluating children with suspected kidney disease 1
  • Assessing prognosis, as non-albumin proteinuria adds independent risk information 2, 4
  • The discrepancy between tests might reveal tubular versus glomerular disease

Important Caveats

Both tests are affected by similar confounding factors 1:

  • Falsely elevated: Hematuria, menstruation, exercise, urinary tract infection, fever
  • Sex differences: Females have lower urinary creatinine excretion, yielding higher ratios for the same protein excretion
  • Body weight: Low weight causes falsely high ratios; high weight causes falsely low ratios

A critical limitation: In advanced CKD (eGFR <15 ml/min/1.73 m²), the albumin-to-protein ratio decreases, making PCR changes less reliable as a surrogate endpoint compared to ACR 6.

Prognostic Value

Both a 30% decrease in ACR and a 30% decrease in PCR over 2 years are comparable surrogate endpoints for kidney failure risk in most CKD patients 6. However, measuring both allows calculation of non-albumin proteinuria, which significantly improves mortality risk prediction (c-statistic improvement from 0.828 to 0.834, p=0.032) 4.

The key distinction is that ACR detects earlier disease when intervention is most effective, while PCR captures the full spectrum of proteinuria including tubular injury markers that independently predict outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.